# Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

> **NCT00268177** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 130 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Salmeterol/fluticasone propionate 50/500mcg Diskus

## Key facts

- **NCT ID:** NCT00268177
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 130 (—)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268177, "Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00268177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*